| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 05/18/2010 | CA2509715C Improved thickened beverages for dysphagia |
| 05/18/2010 | CA2439475C Carbamate compounds for use in preventing or treating bipolar disorder |
| 05/18/2010 | CA2430508C Condensed purine derivatives as a1 adenosine receptor antagonists |
| 05/13/2010 | US20100120919 Methods for treating transthyretin amyloid diseases |
| 05/13/2010 | US20100120705 Compositions and products containing s-equol, and methods for their making |
| 05/13/2010 | US20100119544 Vaccine |
| 05/13/2010 | US20100119515 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 05/13/2010 | US20100119471 Mycoplasma hyopneumoniae bacterin vaccine |
| 05/12/2010 | EP1613340B1 Treatment of aspergillus infections with thymosin alpha 1 |
| 05/12/2010 | EP1578374B1 Escape mutants of newcastle disease virus as marker vaccines |
| 05/12/2010 | EP1564210B9 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 05/12/2010 | CN1916025B Analogs of parathyroid hormone |
| 05/12/2010 | CN1762957B 2,3-dihydro-1-indene compound and preparation method thereof |
| 05/12/2010 | CN1738643B Composition and method for preventing or treating a virus infection |
| 05/12/2010 | CN1426423B Humanized antibodies that sequester amyloid beta peptide |
| 05/12/2010 | CN1366991B Application of plant extract for preparing medicine to cure bone absorption increment diseases, and compositon thereof |
| 05/12/2010 | CN101704810A Cycloalkyl inhibitors of potassium channel function |
| 05/11/2010 | US7713958 Compounds and compositions as protein kinase inhibitors |
| 05/11/2010 | CA2442448C Condom with an erectogenic composition |
| 05/11/2010 | CA2318696C Triazepinones, process for their preparation and their therapeutic application |
| 05/06/2010 | US20100113389 Method of treating graft-rejection using dextran sulfate |
| 05/06/2010 | US20100113334 Methods for reducing or preventing transmission of nosocomial pathogens in a health care facility |
| 05/06/2010 | US20100112035 Multiple component food product useful for delivering glucosamine and/or n-acetyl-d-glucosamine |
| 05/05/2010 | EP1615914B1 Cgrp receptor antagonists |
| 05/05/2010 | EP1592801B1 Method for identifying activated polymer complexes for secondary site-specific modification of protein target groups. |
| 05/05/2010 | EP1572106B1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 05/05/2010 | CN1809353B Medicine for prevention of and treatment for arteriosclerosis and hypertension. |
| 05/05/2010 | CN1787820B Composition for improving cognition and memory |
| 05/05/2010 | CN1682707B Pharmaceutical composition comprising fenofibrate and process for its preparation |
| 05/04/2010 | US7709617 Derivatized with a glycerol linker, 2'-deoxy-7-deazaguanosine and arabinoguanosine; immunomer is self-complementary; anticarcinogenic, antiinflammatory, antiallergen, antihistamine, and bronchodilator agents; asthma, skin disorders |
| 05/04/2010 | US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents |
| 05/04/2010 | US7709479 Quinazoline derivatives and their use as pharmaceuticals |
| 05/04/2010 | US7709476 6-Methoxy-3-(methoxymethyl)-2-methyl-4-phenylisoquinolin-1(2H)-one; treat cardiac arrhythmias |
| 05/04/2010 | US7709220 Methods of monitoring treatment of BAFF-R related disease |
| 05/04/2010 | US7709205 Antiproliferative agents; antiapoptosis; drug screening; blot analysis; immunohistochemistry; RNA interference; fluorescence in situ hybridization; determining prognosis in a subject with breast cancer, comprising determining overexpression of 14-3-3 zeta mRNA |
| 05/04/2010 | US7708977 Method for diagnosis and treatment of vascular disease |
| 05/04/2010 | CA2476587C Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative |
| 05/04/2010 | CA2352484C Pressurised metered dose inhalers (mdi) |
| 04/29/2010 | US20100105712 Chemical compounds |
| 04/29/2010 | US20100105608 Peptides and methods using same for diagnosis and treatment of amyloid-associated disease |
| 04/29/2010 | US20100105151 Novel Druggable Regions in the Dengue Virus Envelope Glycoprotein and Methods of Using the Same |
| 04/28/2010 | EP2180049A1 Devices and compositions for lysis of occlusive blood clots while sparing wound sealing clots comprising a mutant pro-urokinase |
| 04/28/2010 | EP2179742A1 Compositions and methods for the treatment of immune related diseases |
| 04/28/2010 | EP2179724A2 Tamper-resistant products for opioid delivery |
| 04/28/2010 | EP1599228B1 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 04/28/2010 | EP1556513B1 Compositions and methods for treating human papillomavirus-mediated disease |
| 04/28/2010 | CN1777673B Treatment of IgA1 deposition diseases |
| 04/28/2010 | CN1703426B Humanized antibodies that recognize beta amyloid peptide |
| 04/27/2010 | US7705016 administering small molecule capable of inhibiting CPT1(carnitine palmitoyl transferase1) is 2-tetradecylglydate (TDGA) or (R)-N-(tetradecylcarbamoyl)-aminocarnitine |
| 04/27/2010 | US7705006 Anti-cancer cyclopenta[g]quinazoline compounds |
| 04/27/2010 | US7704985 luminally active anti-inflammatory or immunosuppressive compound with minimal or no systemic side effects |
| 04/27/2010 | US7704971 Uracil reductase inactivators |
| 04/27/2010 | US7704947 Methods and compositions for the treatment of gastrointestinal disorders |
| 04/27/2010 | US7704509 Producing an infectious, self-replicating, recombinant human parainfluenza viral particle for use in developing vaccine or preventative against respiratory tract infections |
| 04/22/2010 | US20100098771 Abuse-resistant oral dosage forms and method of use thereof |
| 04/21/2010 | EP2177626A1 Screening methods for cognitive enhancers |
| 04/21/2010 | EP2177620A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/21/2010 | EP2177520A1 1,5-Di(aryl or heteroaryl)-3-halo-2(1H)-pyridones as intermediates for the preparation of AMPA receptor inhibitors |
| 04/21/2010 | EP1592388B1 Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin |
| 04/21/2010 | EP1250328B2 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/21/2010 | CN101696232A Peptidomimetic protease inhibitors |
| 04/20/2010 | US7700775 Drug delivery |
| 04/20/2010 | US7700617 Salt of naphthyridine carboxylic acid derivative |
| 04/20/2010 | US7700591 to prevent or treat inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 04/20/2010 | US7700582 Pharmaceutical formulation |
| 04/20/2010 | US7700560 Compounds comprising two human GlxI inhibitors covalently linked via a diacid where each of the inhibitors may be the same or different and is an S-substituted glutathione or a prodrug thereof having a gamma-glutamyl amino group; length >50 Angstroms; antitumor, -carcinogenic, -proliferative agents |
| 04/20/2010 | US7700548 Using granulocyte colony stimulating factor as therapeutic agent through a slow release mechanism, in treatment of spontaneous abortion, preeclampsia, preterm labor |
| 04/20/2010 | US7700138 Jucara and Açai fruit-based dietary supplements |
| 04/20/2010 | US7700112 FSH beta mutants that are glycosilated at residues N55 and T57 |
| 04/20/2010 | US7700100 FcγRIIB fusion proteins and compositions thereof |
| 04/20/2010 | US7700093 Methods for increasing lactose digestion |
| 04/20/2010 | US7700088 Interleukin-9 mutein peptides |
| 04/20/2010 | CA2515366C Compositions and methods to modulate immune and inflammatory responses |
| 04/20/2010 | CA2425338C Compositions comprising modafinil compounds |
| 04/20/2010 | CA2410579C Methods and compositions for treating flaviviruses and pestiviruses |
| 04/20/2010 | CA2358925C Compositions and methods for use in targeting vascular destruction |
| 04/20/2010 | CA2358519C Dual component dentinal desensitizing dentifrice |
| 04/20/2010 | CA2179779C Vaccine compositions comprising oil in water emulsions with tocopherol and squalene |
| 04/15/2010 | US20100094103 Automated treatment system for sleep |
| 04/15/2010 | US20100093831 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 04/15/2010 | US20100093785 Diamine derivatives |
| 04/15/2010 | US20100092518 Recombinant Intracellular Pathogen Immunogenic Compositions and Methods of Use |
| 04/14/2010 | EP2174649A1 Morinda Citrifolia-Based Oral Care Compositions and Methods |
| 04/14/2010 | EP1599201B1 Selective non-steroidal glucocorticoid receptor modulators |
| 04/14/2010 | CN101693672A Peptidomimetic protease inhibitors |
| 04/13/2010 | US7696244 2-(2-Chloro-benzoylamino)-4,5,6,7-tetrahydro-benzo thiophene-3-carboxylic acid amide; increasing activity of mutant-cystic fibrosis transmembrane conductance regulator protein in a cell; increasing halide ion permeability of a cell producing a Delta F508-CFTR protein |
| 04/13/2010 | US7696214 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
| 04/13/2010 | US7696205 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; 4-Methylsulfanyl-N-{2-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-acetylamino]-cyclohexyl}-benzamide |
| 04/13/2010 | CA2432303C Pyrazole compounds useful as protein kinase inhibitors |
| 04/13/2010 | CA2380805C Improved topical medicaments and methods for photodynamic treatment of disease |
| 04/13/2010 | CA2102112C A substance for lowering high cholesterol level in serum and a method for preparing the same |
| 04/08/2010 | US20100087541 Compounds for the treatment of metabolic disorders |
| 04/08/2010 | US20100087519 Use of equol for treating androgen mediated diseases |
| 04/08/2010 | US20100087478 HIF-1 Inhibitors |
| 04/08/2010 | DE20122915U1 Peptidomimetika als Protease Inhibitoren Peptidomimetics as protease inhibitors |
| 04/07/2010 | EP2172106A1 Allantoin-containing skin cream |
| 04/07/2010 | EP1540335B1 Screening methods for cognitive enhancers |
| 04/07/2010 | CN1813753B Low dose entecavir formulation and use |
| 04/06/2010 | US7692017 Such as 2-(Allyloxy)-4-(3-fluorophenyl)-6-methoxyquinoline-3-carbonitrile; for treating cardiac arrhthymias |
| 04/06/2010 | US7691904 Diisopropylphenyl esters of N-amino- or N-heterocyclyl-alkanamic acids, e.g., N-(2-Piperidin-1-yl-ethyl)-succinamic acid 2,6-diisopropylphenyl ester; induction and maintenance of anesthesia or sedation as well as treating cancer, nervous system disorders and respiratory system disorders, |